Immunological and endocrinological abnormalities in paraneoplastic disorders with involvement of the autonomie nervous system

Italian Journal of Neurological Sciences

Volumn 18, Issue 3, 1997, Pages 157-161

  Riva, M ^a   Brioschi, A M ^a   Marazzi, R ^a   Donato, M F ^a   Ferrante, E ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Autonomie dysfunctions; paraneoplastic syndromes

Indexed keywords

AGED; ARTICLE; AUTONOMIC NEUROPATHY; CASE REPORT; COLON TUMOR; HUMAN; IMMUNOLOGY; LEUKEMIA; LUNG TUMOR; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROME; PATHOPHYSIOLOGY;

AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; COLONIC NEOPLASMS; HUMANS; LEUKEMIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES;

EID: 0031158173     PISSN: 03920461     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02048484     Document Type: Article

References (35)

1. CLOUSTON PD, DE ANGELIS LM, POSNER JB. The spectrum of neurological disease in patients with systemic cancer. Ann Neural, 1992; 31: 268-273.
2. SCULIER JP, FELD R, EVANS WK et al. Neurologic disorders in patients with small cell lung cancer. Cancer, 1987; 60: 2275-2283.
3. O'NEiLL JH, MURRAY NMF, The Lambert-Eaton myasthénie syndrome. A. review of 50 cases. Brain, 1988; 111: 577-596.
4. 2+ channels shared by cancer cells and motor nerve terminals. Progr Neuro-EndocrinolImmunol., 1988; 1: 39-40.
5. VINCENT A, LANG B, NEWSON-üAVIS J. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthénie syndrome, a paraneoplastic disorder. Trends Neurosci, 1989; 12: 496-502.
6. ROSENFELD MR, WONG E, DALMAU J. et al. Cloning and characterization of a Lambert-Eaton myasthénie syndrome antigen. Ann Neurol, 1993; 33: 113-120.
7. GRAUS F., BONAVENTURA I., UCHUYA M. et al. Indolent anti-Hu-associated paraneoplastic sensory neuropathy. Neurology, 1994; 44: 2258-2261.
8. SCHUFFLER MD, BAiRD HW, FLEMING CR et al. Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung. A paraneoplastic neuropathy of the gastrointestinal tract. Ann Intern Med, 1983; 98: 129-134.
9. FROHMAN LA. Endocrine manifestations of neoplasia. In: Wilson JD, Braunwald E, Isselbacher KJ et al., eds. Harrison's Principles of Internal Medicine. 12th ed.: McGraw-Hill, Inc, 1991; 309: 1638-1654.
10. IVY HK. Renal sodium loss and bronchogenic carcinoma. Arch Intern Med, 1961; 108: 115-123.
11. [ll]SiEMSEN JK, MEISTER L. Bronchogenic carcinoma associated with severe orthostatic hypotension. Ann Intern Med, 1963; 58: 669-676.
12. BARRACLOUGH MA, SHARPEY-SCHAFER EP. Hypotension from absent circulatory reflexes. Effects of alcohol, barbiturates, psychotherapeutic drugs, and other mechanisms. Lancet i, 1963: 1121-1126.
13. THOMAS JP, SHIELDS R. Associated autonomie dysfunction and carcinoma of the pancreas. BMJ, 1970; 4: 32.
14. LHERMITTE F, GAUTIER JC, ESCOUROLLE R, DEROUESNE C, VERON JP. Hypotension orthostatique et neuropathic périphérique au cours de l'évolution d'un carcinome bronchique. Presse Méd, 1970; 78: 257-260.
15. QUINLAND CD. Autonomie neuropathv in carcinoma of the lung. J Irish Med Assoc, 1971; 64: 430-431.
16. PARK MD, JOHNSON RH, CREAN GP, ROBINSON JF. Orthostatic hypotension in bronchial carcinoma. BMJ, 1972; 3: 510-511.
17. CHIAPPA KH, YOUNG RR. A case of paracarcinomatous pandysautonomia. Neurology (abstract), 1973; 23: 423.
18. AHMED MN, CARPENTER S. Autonomie neuropathy and carcinoma of the lung. Can Med Assoc J, 1975; 113: 410-412.
19. BOASBERG PD, HENRY JP, ROSENBLOOM AA, HALE TC, ROSE M. et al. Case reports and studies of paraneoplastic hypotension: abnormal pressure baroreceptor responses. Med Pediatr Oncol, 1977; 3: 59-66.
20. CHATTERJEE SB, BARAT D, KHAN SK. Autonomie neurogenic bladder in a case of bronchogenic carcinoma. J Indian Med Assoc, 1978; 71: 205-207.
21. GREEN GJ, BRECKENRIDGE AM, WRIGHT FK. Severe hypotension associated with carcinoma of the bronchus. Postgrad Med J, 1979; 55: 426-429.
22. CARR-LOCKE DL. Autonomie neuropathy and inappropriate secretion of Antidiuretic Hormone. Occurrence in a patient with bronchogenic carcinoma. JAMA, 1979; 241: 2298.
23. LHERMITTE F, GRAY F, LYON-CAEN O, PERTUISET BF, BERNARD P. Paralysie du tube digestif avec lésion des plexus myentériques. Nouveau syndrome paranéoplasique possible. Rev Neurol (Paris), 1980; 136: 825-836.
24. MOUSA AR, AL-DiR AN. Neurological and cardiac complications of carcinoma of the breast. Acta Neurol Scand, 1985; 72: 518-521.
25. MALAGELADA JR, CAMILLERI M, STANGHELLINI V. Manometric diagnosis of gastrointestinal motility disorders. New York, Thieme Inc, 1986.
26. CHINN JS, SCHUFFLER MD. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology, 1988; 95: 1279-1286.
27. SHODI N, CAMILLERI M, CAMORIANO JK, Low PA, FEALEY RD et al. Autonomie function and motility in intestinal pseudo-obstruction caused by paraneoplastic syndrome. Dig Dis Sei, 1989; 34: 1937-1942.
28. VEILLEUX M, BERNIER JP, LAMARCHE JB. Paraneoplastic encephalomyelitis and subacute dysautonomia due to an occult atypical carcinoid tumor of the lung. Can J Neurol Sei, 1990; 17: 324-328.
29. LENNON VA, SAS DF, BUSK MF et al. Enteric neuronal autoantibodies in pseudo-obstruction with small-cell lung carcinoma. Gastroenterology, 1991: 100: 137-142.
30. CHU G, WILSON PC, CARTER CD, LENNON VA, ROBERTSTHOMSON 1C. Intestinal pseudo-obstruction, type l antineuronal nuclear antibodies and small-cell carcinoma of the lung. J Gastroenterol Hepatol, 1993; 8: 604-606.
31. CONDOM E, VIDAL A, ROTA R et al. Paraneoplastic intestinal pseudo-obstruction associated with high titres of Hu antibodies. Virchows Arch A Pathol Anat Histopathol, 1993; 423: 507-511.
32. ROSENBLUM MK. Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome. Brain Pathology, 1993; 3: 199-212.
33. VEGA F, GRAUS F, CHEN QM et al. Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomvelitis or sensory neuronopalhy. Neurology, 1994; 44: 2145-2147.
34. DALMAU J, POSNER JB. Neurologic paraneoplastic antibodies (anti-Yo: anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology, 1994; 44: 2241-2246.
35. LENNON VA. Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology, 1994; 44: 2236-2240.